(E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C1=CC(=CC=C1/C=C/C(=O)O)O

InChI=1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3+

NGSWKAQJJWESNS-ZZXKWVIFSA-N

4-Hydroxycinnamic acid; p-coumaric acid; 501-98-4; p-Hydroxycinnamic acid; 4-Coumaric acid; trans-4-Hydroxycinnamic acid; 7400-08-0; trans-p-Coumaric acid; p-Cumaric acid; 3-(4-hydroxyphenyl)acrylic acid; Para-Coumaric acid; Hydroxycinnamic acid; Naringeninic acid; p-Hydroxy-cinnamic acid; (E)-p-Coumaric acid; (E)-3-(4-Hydroxyphenyl)acrylic acid; trans-4-coumaric acid; trans-p-Coumarinic acid; 4'-hydroxycinnamic acid; 2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)-; p-Hydroxyphenylacrylic acid; Cinnamic acid, p-hydroxy-; (E)-p-Hydroxycinnamic acid; trans-p-Hydroxycinnamic acid; 3-(4-Hydroxyphenyl)-2-propenoic acid; (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid; (E)-3-(4-hydroxyphenyl)prop-2-enoic acid; 4-coumarate; trans-p-Hydroxycinnamate; 2-Propenoic acid, 3-(4-hydroxyphenyl)-; 4-Hydroxycinnamate; Cinnamic acid, p-hydroxy-, (E)-; (E)-3-(4-Hydroxyphenyl)-2-propenoic acid; 3-(4-hydroxyphenyl)prop-2-enoic acid; trans-4-hydroxycinnamate; (2E)-3-(4-hydroxyphenyl)acrylic acid; beta-(4-Hydroxyphenyl)acrylic acid; Para coumaric acid; (E)-4-hydroxycinnamic acid; NSC 59260; 4-Hydroxycinamic acid; IBS9D1EU3J; 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)-; 4-hydroxy cinnamic acid; CHEMBL66879; CHEBI:32374; beta-[4-Hydroxyphenyl]acrylic acid; NSC-59260; NSC674321; NSC-674321; 50940-26-6; trans-p-coumarate; 3-(4-hydroxyphenyl)acrylate; MFCD00004399; .beta.-[4-Hydroxyphenyl]acrylic acid; parahydroxycinnamic acid; (E)-3-[4-hydroxyphenyl]-2-propenoic acid; 4-Hydroxycinnamicacid; trans-p-Cumaric Acid; .BETA.-(4-HYDROXYPHENYL)ACRYLIC ACID; 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (Z)-; EINECS 231-000-0; UNII-IBS9D1EU3J; NSC 674321; CHEBI:36090; BRN 2207381; BRN 2207383; hydroxycinnamate; Para coumarate; p-coumaric-acid; Para-Coumarate; p-Cumarate; naringeninic-acid; p-Hydroxycinnamate; 4qem; Coumaric acid, p-; 4'-Hydroxycinnamate; 4-Hydroxy cinnamate; p-Coumaric acid,trans; ORISTAR PCA; p-Coumaric acid 98%; 4f8j; p-Coumaric acid, trans; 4-Hydroxyphenylpropenoate; (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid; bmse000150; bmse000591; bmse010208; trans-4-HydroxycinnamicAcid; b-[4-Hydroxyphenyl]acrylate; SCHEMBL39106; p-hydroxycinnamic acid (M4); 0-10-00-00297 (Beilstein Handbook Reference); 4-10-00-01005 (Beilstein Handbook Reference); MLS001066419; p-Hydroxycinnamic acid, trans; P-COUMARIC ACID [MI]; beta-[4-Hydroxyphenyl]acrylate; BDBM4374; GTPL5787; PARA HYDROXYCINNAMIC ACID; SODIUM2,4-PENTANEDIONATE; b-[4-Hydroxyphenyl]acrylic acid; trans-p-HydroxyzimtsA currencyure; ZINC39811; DTXSID30901076; P-COUMARIC ACID [WHO-DD]; HMS1409E10; 3-(4-Hydroxyphenyl)-2-propenoate; HYDROXYCINNAMIC ACID [INCI]; BCP22803; HY-N2391; NSC59260; STR06515; 4-HYDROXYPHENYLPROPENOIC ACID; Cinnamic acid, 4-hydroxy-, trans-; AC7957; BBL012226; CK2547; s4759; s9564; STL163567; AKOS000120685; p-Coumaric acid;p-Hydroxycinnamic acid; BCP9001042; CCG-266309; CS-W020394; DB04066; p-Coumaric acid, >=98.0% (HPLC); (E)-3-(4-hydroxyphenyl)prop-2-enoate; NCGC00246974-01; AC-10318; AC-34130; AC-34133; AS-12000; BP-13278; SMR000112201; (E)-3-(4-hydroxyphenyl)prop-2-enoicacid; trans-p-Coumaric acid, analytical standard; AM20050138; EN300-17292; A14559; A19490; C00811; Q99374; (2E)-3-(4-Hydroxyphenyl)-2-propenoic acid #; 400H080; A828008; AE-562/40414679; trans-p-Coumaric acid 1000 microg/mL in Acetone; Q-100560; W-104438; Z56911963; 0C1BFF2D-2CF7-4FC1-9F76-3268C2C7F783; F2191-0188; p-Coumaric acid, primary pharmaceutical reference standard; p-coumaric acid methyl ester geometric isomer (tentative, MSe); (E)-3-(4-hydroxyphenyl)prop-2-enoate;Trans-4-Hydroxycinnamic Acid